Summary: Nyxoah SA has appointed Scott Holstine as chief commercial officer to lead the expected US launch of the Genio neurostimulator for obstructive sleep apnea (OSA). The Genio system, which has already received the CE Mark in Europe, is expected to receive FDA approval by … [Read more...]
Natus Appoints Veteran Medical Device Leader as New CEO
Summary: Natus has appointed Chris Landon as its new CEO. Landon brings over two decades of experience in the medical device industry, focusing on image-guided therapy devices, cardiology, and neurodiagnostics. He previously held executive roles at Philips and Medtronic and … [Read more...]
AdaptHealth Appoints Healthcare Industry Veteran as CEO
Summary: AdaptHealth Corp has introduced the appointment of a new CEO, beforehand the president at Beckman Coulter Lifetime Sciences, section of Danaher Corp, productive May well 20. The new CEO, with more than 25 years in the health care field, like roles at Cardinal Wellness … [Read more...]
Nyxoah Appoints Hypoglossal Nerve Stimulation Pioneer as CMO
Summary: Nyxoah SA has appointed Maurits S. Boon, MD, who is acknowledged for his get the job done in hypoglossal nerve stimulation remedy to deal with obstructive snooze apnea, as chief clinical officer. Boon, from Thomas Jefferson University, contributed to Nyxoah’s Desire US … [Read more...]